PRESS RELEASE published on 06/06/2024 at 11:32, 2 years ago Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Medios AG completes acquisition of Ceban, expanding market position in Europe. Ceban, a pharmaceutical compounding platform, adds strategic diversification and growth opportunities Acquisition Medios AG Pharmaceutical Compounding Ceban Pharmaceuticals B.V. European Market Position
BRIEF published on 05/07/2024 at 07:36, 2 years 1 month ago Medios AG Reports Revenue Growth in Q1 2024 and Confirms Yearly Targets Revenue Growth Financial Guidance Medios AG Specialty Pharma Ceban Acquisition
BRIEF published on 05/07/2024 at 07:36, 2 years 1 month ago Medios AG annonce une croissance de son chiffre d'affaires au premier trimestre 2024 et confirme ses objectifs annuels Medios AG Hausse Des Revenus Conseils Financiers Pharmacie Spécialisée Acquisition Du Céban
PRESS RELEASE published on 05/07/2024 at 07:31, 2 years 1 month ago Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance Medios AG reports 5.8% revenue growth in Q1 2024, reaching €456.2 million. Full-year guidance confirmed, anticipating significant revenue and margin increase. Acquisition of Ceban planned for May 2024 Revenue Growth Medios AG Q1 2024 Full-year Guidance Ceban Acquisition
BRIEF published on 05/06/2024 at 14:24, 2 years 1 month ago Medios AG Appoints Constantijn van Rietschoten to Executive Board Medios AG International Markets Executive Appointment Constantijn Van Rietschoten European Pharma
BRIEF published on 05/06/2024 at 14:24, 2 years 1 month ago Medios AG nomme Constantijn van Rietschoten au conseil d'administration Medios AG Marchés Internationaux Nomination À La Direction Constantin Van Rietschoten Pharmaceutique Européenne
PRESS RELEASE published on 05/06/2024 at 14:19, 2 years 1 month ago Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets Medios AG appoints Constantijn van Rietschoten as Executive Board member for International Markets, effective May 1, 2024, expanding focus on international growth Growth Medios AG International Markets Constantijn Van Rietschoten Executive Board Member
BRIEF published on 03/27/2024 at 07:59, 2 years 2 months ago Medios AG Announces Strong Performance in 2023 and Promising Outlook for 2024 and 2025 Financial Performance 2024 Outlook Medios AG Pharmaceutical Supply Patient-Specific Therapies
BRIEF published on 03/27/2024 at 07:59, 2 years 2 months ago Medios AG annonce de solides performances en 2023 et des perspectives prometteuses pour 2024 et 2025 Performance Financière Perspectives 2024 Medios AG Approvisionnement Pharmaceutique Thérapies Spécifiques Au Patient
PRESS RELEASE published on 03/27/2024 at 07:54, 2 years 2 months ago Medios achieves double-digit growth in 2023 – Positive outlook for 2024 Medios AG achieves double-digit growth in 2023, with revenue reaching around €1.8 billion and EBITDA pre up by 10.3%. Positive outlook for 2024 and 2025 financial years EBITDA Revenue 2024 Outlook Double-digit Growth Medios AG
Published on 06/26/2026 at 13:00, 8 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 11 hours 28 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 38 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 38 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 12:18, 49 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 38 minutes ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 1 hour 53 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 2 hours 2 minutes ago Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 07:00, 6 hours 8 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 8 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 23 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 38 minutes ago Avis financier semestriel SIEHM au 30 avril 2026